Acta Neurologica Scandinavica · 2009 · 24 citations · 25 references
Life SciencesImmunologyPathologyImmunogeneticsImmunopathologyNeuroimmunologyAutoimmune Disease Susceptibility GenesAutoimmune DiseasesComplement SystemGenetic Susceptibility To AutoimmunityImmune-mediated Inflammatory DiseasesMultiple SclerosisC3 Complement LevelsComplement In Autoimmune DiseaseComplement PolymorphismsComplement System GenesImmunological MechanismsMultiple Sclerosis AssociationsMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis Immunopathology
The phenotypes of the complement factor C3 have been evaluated in 60 patients with multiple sclerosis (M.S.), and the results correlated to the occurrence of circulating immune complexes (CIC). A significantly increased frequency of the C3F-gene was found among the patients, and closely associated with the occurrence of CIC. A relative risk incidence of 4.1 was found for C3F-positive individuals among M.S. patients with detectable CIC. Low C3 levels in serum were found in 30% of the patients, almost all belonged to the group without CIC and showed a C3-type distribution similar to normal controls. A different immunological reaction pattern (type II reaction) in these patients seems possible, and a genetically determined immunological abnormality predisposing to M.S. is therefore suggested.
25
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
Barnet Woolf · Annals of Human Genetics · 1955 · 2.7K citations
C.‐B. Laurell · Scandinavian Journal of Clinical and Laboratory Investigation · 1972 · 1.7K citations
George A. Schumacher, Gilbert W. Beebe, Robert F. Kibler et al. · Annals of the New York Academy of Sciences · 1965 · 1.4K citations
Measles Antibodies in Multiple Sclerosis.
J. M. Adams, David T. Imagawa · Experimental Biology and Medicine · 1962 · 318 citations
Life Sciences, Immunology, Neurology +15